|4Dec 10, 7:53 AM ET

Apuli Maricel 4

4 · BridgeBio Pharma, Inc. · Filed Dec 10, 2025

Insider Transaction Report

Form 4
Period: 2025-12-08
Apuli Maricel
Chief Accounting Officer
Transactions
  • Sale

    Common Stock

    2025-12-08$74.26/sh2,000$148,520130,297 total
Footnotes (1)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025.

Documents

1 file
  • 4
    wk-form4_1765371229.xmlPrimary

    FORM 4